Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home /
  2. News /
  3. Health & wellness /
  4. By the numbers: Understanding the toll of inflammatory bowel disease
Person with hand on stomach

By the numbers: Understanding the toll of inflammatory bowel disease

For Colitis and Crohn’s Disease Awareness Week, learn about the challenges of this painful condition—and why Johnson & Johnson continues to seek new treatment options.

Living with Crohn’s disease or ulcerative colitis—collectively known as inflammatory bowel disease (IBD)—isn’t easy. Characterized by chronic inflammation of the digestive tract, IBD is an immune-mediated condition that typically causes diarrhea, weight loss, fatigue and abdominal pain .

But the burden of living with IBD goes beyond the physical pain. People with IBD often talk about the shame and embarrassment of having a “bathroom” disease. No surprise, this can lead to mental health problems such as depression and anxiety.

Treatment for people with IBD has improved dramatically in the past 25 years since biologic drugs entered the picture. But a significant portion of patients don’t respond to these medications or find that they eventually stop working. That’s why Johnson & Johnson is committed to developing new remedies, in addition to precision medicine approaches that will help speed up diagnosis and help healthcare providers match patients to the best treatment.

For Colitis and Crohn’s Disease Awareness Week, we’re taking a look at the impact of this painful condition across the globe—and some of the reasons why hope is on the horizon.

Understanding the toll of inflammatory bowel disease infographic

More from Johnson & Johnson

Introducing the first and only daily disposable multifocal contact lens for people with astigmatism

A Johnson & Johnson scientist explains how the new Acuvue® Oasys Max 1-Day Multifocal for Astigmatism contact lens also filters blue light, supports the eye’s natural tear film and helps eyes easily switch focus from distance to reading.

What is wAIHA?

Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.

Could we be on our way to eliminating cancer for good?

What once seemed like an unattainable goal may soon be within our grasp. Learn how Johnson & Johnson is working toward its vision to create a world without cancer.